* Note: Prices are in Million (M) USD.
Description:
Aurora Cannabis Inc. (ACB), headquartered in Edmonton, Canada, is a leading player in the global medical cannabis market with a strong focus on innovation and quality. The company offers a comprehensive portfolio of cannabis products aimed at addressing the diverse needs of patients worldwide, underpinned by robust research and development initiatives. With a commitment to advancing the medical cannabis sector, Aurora is strategically positioned to seize growth opportunities within an expanding market while maintaining its reputation as a trusted industry leader. As the landscape evolves, Aurora's expertise and strategic focus on quality and compliance continue to differentiate it from competitors.
These criteria used Company's Cash, EBITDA and Debt balance to determines its fair value:
Cash : $96 M
Debt : $60 M
EBITDA : $107 M
Since Cash is greater than Total Debt, 5 points assigned.
This criteria used industry in which company operates:
Sector: Healthcare
Industry: Drug manufacturers - specialty & generic
Based on industry, 3 points assigned.
This criteria used Company's Price To Earning (P/E) Ratio to determines its fair value:
Forward PE Ratio: 30.12
Since Forward PE Ratio is between 25 - 35, 1 point assigned.
This criteria used Company's ability to convert Sales into free cash flow to determine fair value:
Using last 19 overlapping fiscal years (max 20).Average Free Cash Flow: $-116 M
Average Revenue: $100 M
Revenue Converted To Free Cash Flow (%): -116.3%
Since Free Cash Flow (FCF) to Revenue percentage is non-positive, 0 point assigned.
This criteria used company's growth potential to calculate its fair value:
Latest Revenue (2025-03-31): $343 M
Revenue 5 Years Ago (2020-03-31): $269 M
Total Growth over 5 Years: 27.8%
5-Year Revenue CAGR (Historical): 5.0%
Forward 5-Year CAGR (Tapered): 4.5%
Since historical Revenue CAGR is between 5 - 10, 2 points assigned.
This criteria used Company's ability to buy back its own share:
Latest Share Count (2025-03-31): $56 M
Share Count 5 Years Ago (2021-03-31): $17 M
Company is not buying back its own shares, 0 points assigned.
This criteria used Company's dividend payout ratio to determine its fair value:
Next Year Earnings Per Share (EPS): $0.17
Trailing 12-Month Earnings Per Share (EPS): $0.00
Average Earnings Per Share (EPS): $0.17
Dividend Per Share (DPS): $0
Payout Ratio: 0%
Dividend Yield: 0.00%
Since Dividend Per Share is less than or equal to 0, 0 point assigned.
Since Dividend Yield is less than 1, 0 point assigned.
This criteria used Company's Return On Equity (ROE%) to determine its fair value:
Using last 19 valid ROE years (max 20).Average ROE: -59.9%
Since Average ROE is non-positive, 0 point assigned.
This criteria used Company's current price to its 52 week low price to determines its fair value:
Current Price: $5.12
52-Week Low: $3.42
Threshold Price (15% Above 52-Week Low): $3.94
Since Current price is not within 15% threshold, 0 point assigned.
This criteria used Company's Market Cap to determines its fair value:
Market Capitalization: $238 M
Since Market Cap is less than 10B, 1 point assigned.
% Exposure to Total Portfolio
Based on the market cap, we recommend do not exceed 0.5% exposure of Total Portfolio.
Warren Buffett's Owners' Earnings:
No positive free cash flow found (TTM or annual) to compute Owners' Earnings per share.
Note: Many fast-growing companies reinvest heavily, so Owners' Earnings may appear low.
Consider other factors in your valuation.
Value-Trade has assigned 12 points to above Aurora Cannabis Inc (ACB) stock.
Fair Value PE
12, Industry Based PE
15, Growth Based PE
15, Risk-Free Anchored PE (25% MoS)
18.34. Based on these 4 values, average assigned is
15.08. Value-Trades has assined P/E value
15.06. An average (Current Year EPS + Next Year EPS) earning per share is
$0.17.
Fair value using multiple P/Es (blended): $2.56 (PE 15.08 × EPS $0.17)
So the Final Fair Value is: $2.56
Understanding the Value-Trades P/E Blend (click to expand)
▾
What goes into the blended P/E?
- 20-Year Avg P/E — Long-run market baseline; conservative anchor.
- Fair Value P/E — Score-based (cash, debt, sector, etc.).
- Industry P/E — Peer group norm.
- Growth-Based P/E — Uses tapered growth rates, floored at 15.
- RCFC-Based P/E — Maps cash conversion efficiency.
- ROE-Based P/E — Higher ROE supports higher multiples.
- Risk-Free Anchored P/E — Macro floor tied to 10y yield w/ MoS.
How it works
- Extreme values are clamped/filtered (IQR method).
- Anchors (20y avg, RCFC/ROE, risk-free) are always kept if valid.
- Final fair value = min(Blended PE × EPS, Avg PE × EPS).
P/E Reference Summary
Using EPS: $0.17
| Source |
P/E Ratio |
Implied Fair Value |
| Market (1 Yr Ago) | 236.7 | $40.24 |
| Value-Trades Assigned | 15.06 | $2.56 |
